Skip to Main Content
An official website of the United States government

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Filter results of approved projects table below

Approved Projects
Name Principal Investigator Institution Study Date Approved Project ID
Foundation Models for Lung Cancer Screening and Prognostics- Jia Wu University of Texas MD Anderson Cancer Center NLST Aug 25, 2025 NLST-1451
Foundation Models for Multi-Cancer Screening and Prognostics using PLCO Data Jia Wu University of Texas MD Anderson Cancer Center PLCO Mar 12, 2025 PLCOI-1857
Foundation models for precision non-small cell lung cancer treatment Mitchell Chen Imperial College London NLST Jan 26, 2026 NLST-1490
Framework for quantifying the effects of screening interventions using intermediate trial outcomes Vichithranie Madurasinghe University of Warwick NLST Oct 21, 2024 NLST-1344
From clinical trials to real world practice: health status of community-dwelling veterans receiving lung cancer screening compared to randomized trial participants Alison Rustagi University of California, San Francisco NLST Apr 18, 2024 NLST-1236
From physiology to pathology Gabriela Epihova University of Cambridge PLCO Oct 16, 2024 PLCO-1711
Fully automated end to end analysis of non-small-cell lung carcinoma using deep learning techniques Eranga Ukwatta University of Guelph NLST Jan 26, 2022 NLST-871
Functional DNA Repair Assays for Lung Cancer Risk: Prospective Analysis Alice Sigurdson NCI PLCO 2005-0013
Functional Genomics to Inform Gene Environment Interactions Ulrike Peters Fred Hutchinson Cancer Center PLCO Oct 12, 2017 PLCO-310
Functional Relationships between Body Composition, Energy Expenditure and Daily Food Intake Mark Hopkins University of Leeds IDATA Aug 6, 2018 IDATA-23
Future diagnosis prediction of lung cancer using convolutional and recurrent networks. Latifur Khan University of Texas at Dallas NLST Oct 31, 2018 NLST-449
Gastric Cancer Cohort Consortium Study Neal Freedman NCI, DCEG, NEB PLCO Jan 23, 2009 2008-0213
GBV-C INFECTION AND RISK OF NHL IN THE PLCO COHORT Cindy Chang NCI, DCEG, IIB PLCO Sep 23, 2010 2010-0135
Genderd differences in stage and radiotherapy Cristina Sarasqueta Instituto Biodonostia PLCO Jun 26, 2020 PLCO-640
Gender difference in benefits of lung cancer screening Soon Ho Yoon Seoul National University Hospital NLST Jan 2, 2019 NLST-465
Gender Differences in Lung Cancer Screening in NLST Data: A Comparative Analysis Mohamed Rahouma Weill Cornell Medicine/ New York Presbyterian Hospital NLST Mar 8, 2023 NLST-1023
Gender-specific susceptibility and hormonal influence on lung cancer incidence Juan Wisnivesky Icahn School of Medicine at Mount Sinai NLST Mar 6, 2019 NLST-487
Gender-specific susceptibility and hormonal influence on lung cancer incidence Juan Wisnivesky Icahn School of Medicine at Mount Sinai PLCO Mar 25, 2019 PLCO-460
Gene Polymorphisms Involved in Methylation Pathway and Prostate Cancer in the PLCO Trial - DNMT1, MTHFR, MTR, MTRR, CBS Iqbal Ali NCI, DCP, LCP PLCO Jul 1, 2006 2006-0028
Generalization of chest x-ray deep learning models Santiago Ibanez Caturla Hospital Universitario Virgen de la Arrixaca PLCO May 18, 2020 PLCOI-625